您的位置: 首页 > 农业专利 > 详情页

Formulation comprising phenylaminopyrimidine derivative as active agent
专利权人:
Natco Pharma Limited
发明人:
Parvataneni, Durga Maheswari,Yedluri, Siddhartha,Appadwedula, Venkata Satyanarayana,Adibhatla, Kali Satya Bhujanga Rao,Nannapaneni, Venkaiah Chowdary
申请号:
AU2011361921
公开号:
AU2011361921A2
申请日:
2011.08.10
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs such as Form I, Form II and Form III thereof to improve the bioavailability intended for self-emulsification upon its contact with the gastro-intestinal fluid. The invention also relates to a process for the preparation of oral solution containing NRC-AN-019 in an effective concentration for the better therapy against Chronic Myeloid Leukemia as BCR-ABL tyrosine kinase inhibitor and against other tumors such as head and neck cancer, prostate cancer and the like.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充